US Stock MarketDetailed Quotes

BLUE bluebird bio

Watchlist
  • 0.504
  • +0.007+1.39%
Close Sep 27 16:00 ET
  • 0.505
  • +0.001+0.12%
Post 20:01 ET
97.81MMarket Cap-204P/E (TTM)

bluebird bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

bluebird bio Q2 2024 Earnings Date

Currency：USDAug 14, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
23.23M
16.10M
-7.13M
Miss Est.
+237.20%
+133.69%
-30.70%
EPS
-0.36
-0.42
-0.06
Miss Est.
+46.38%
+27.59%
-16.93%
Analyst Rating
Buy

Sep 27, 2024

bluebird bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 28.294M--
--2024/Q3-- / 18.252M--
Aug 14, 20242024/Q216.100M / 23.233M--
May 9, 20242024/Q118.573M / 16.600M--
Mar 26, 20242023/Q47.834M / 14.157M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 28.294M--
--2024/Q3-- / 18.252M--
Aug 14, 20242024/Q216.100M / 23.233M--
May 9, 20242024/Q118.573M / 16.600M--
Mar 26, 20242023/Q47.834M / 14.157M--

Unlock Free Earnings Estimates

bluebird bio Earnings Reports

  • bluebird bio | 10-Q: Q2 2024 Earnings Report

    16:24 ET

  • bluebird bio | 10-Q: Q1 2024 Earnings Report

    Sep 13 16:42 ET

  • bluebird bio | 10-K: FY2023 Annual Report

    Sep 13 16:33 ET

  • bluebird bio | 10-Q: Q3 2023 Earnings Report

    Nov 7, 2023 07:03 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 27, 2024

    Buy

    • Buy

      30.00%

    • Hold

      70.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept CAR-T Therapy
    CAR-T Therapy
    Intraday+0.26%
    Gene Editing
    Gene Editing
    Intraday+0.22%